Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Immuron Receives FDA Feedback On Pre-IND Package For IMM-529 To Prevent Or Treat Clostridioides Difficile Infection (CDI); Plans To File IND Application In 1H 2025, Followed By Phase 2 Trial

Author: Benzinga Newsdesk | September 05, 2024 08:11am

Posted In: IMRN